Amendment of Solicitation/Modification of Contract 0001, dated February 21, 2019, to Agreement, dated September 10, 2018, between the Biomedical Advanced Research and Development Authority of the United States Department of Health and Human Services and SIGA

 

 

 

2. AMENDMENT/MODIFICATION NO. 
0001

3. EFFECTIVE DATE 
See Block 16C

4. REQUISITION/PURCHASE REQ. NO. 
OS235415

5. PROJECT NO. (If applicable)

7. ADMINISTERED BY (If other than Item 6)

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State, and Zip Code)

SIGA TECHNOLOGIES, INC. 1385150
SIGA TECHNOLGIES, INC.
31 East 62^nd Street
NEW YORK, NY 100658446

 

 

 

 

 

9B. DATED (SEE ITEM 11)

 

 

10A. MODIFICATION OF CONTRACT/ORDER NO. 
HHSO100201800019C

 

 

 

10B. DATED (SEE ITEM 13)

CODE 1385150

 

 

 The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended,   is not extended. Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
(a) By completing Items 8 and 15, and returning _____ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required) Net Increase: $12,186,975.00

A. THIS CHANGE ORDER IS ISSUED PURSUANT TO:  (Specify authority)  THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

 

 

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF: 
FAR 43.103(a) Bilateral Modification; FAR 17.207(c) (1) Exercise of Options with Avaliable Funds

 

D. OTHER (Specify type of modification and authority

E. IMPORTANT:  Contractor     is not,  is required to sign this document and return       1      copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

Tax ID Number: 13 ###-###-####
DUNS Number: 932651516
Procurement and Late-Stage Development of Smallpox Antiviral Drug(s) 

The purpose of this modification is to exercise Option CLIN0007 in the amount of $12,186,975.00 and change the COR information listed in Article G.2 as follows.
Delivery: 12/31/2023
Delivery Location Code: HHS/OS/ASPR
HHS/OS/ASPR

200 C St SW

WASHINGTON DC 20201 US 
Continued ...

 

15A. NAME AND TITLE OF SIGNER (Type or print) 
Dennis E Hurby, CSO

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

 

15B. CONTRACTOR/OFFEROR 
/s/ Dennis E Hurby, CSO

15C. DATE SIGNED 
19 Feb 2019

 

 

NSN 7540-01-152-8070

Previous Edition Unusable

STANDARD FORM 30 (Rev. 10-83)

Prescribed by GSA

FAR (48 CFR) 53.243